Cited by 178IL-33, ST2, and ILC PathwaysInflammatory Bowel DiseaseDigestive system and related health

Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation

Open access
He, Gui-Wei, Lin, Lin, DeMartino, Jeff, Zheng, Xuan, Staliarova, Nadzeya, Dayton, Talya, Begthel, Harry, van de Wetering, Willine J. +11 more·2022·Cell Stem Cell

Abstract

Opposing roles have been proposed for IL-22 in intestinal pathophysiology. We have optimized human small intestinal organoid (hSIO) culturing, constitutively generating all differentiated cell types while maintaining an active stem cell compartment. IL-22 does not promote the expansion of stem cells but rather slows the growth of hSIOs. In hSIOs, IL-22 is required for formation of Paneth cells, the prime producers of intestinal antimicrobial peptides (AMPs). Introduction of inflammatory bowel disease (IBD)-associated loss-of-function mutations in the IL-22 co-receptor gene IL10RB resulted in abolishment of Paneth cells in hSIOs. Moreover, IL-22 induced expression of host defense genes (such as REG1A, REG1B, and DMBT1) in enterocytes, goblet cells, Paneth cells, Tuft cells, and even stem cells. Thus, IL-22 does not directly control the regenerative capacity of crypt stem cells but rather boosts Paneth cell numbers, as well as the expression of AMPs in all cell types.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2022.08.002

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Time-resolved scRNA-seq on a KRAS G12D PDO treated with MRTX1133 and cetuximab showed a gradual increase in Paneth-like gene module activity over time, supporting a stepwise transition during treatment.

    “We scored the CRC PDO cells for the published Paneth-like state signatures38,39 and observed a gradual increase in Paneth-like gene module activity over time (Figure S1P), supporting a stepwise transition during treatment.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. Angerer P. Haghverdi L. Büttner M. Theis F.J. Marr C. Buettner F. Destiny: diffusion maps for large-scale single-cell data in R Bioinformatics 32 2016 1241 1243 26668002
  2. Araujo A. Safronova A. Burger E. López-Yglesias A. Giri S. Camanzo E.T. Martin A.T. Grivennikov S. Yarovinsky F. IFN-gamma mediates paneth cell death via suppression of mTOR Elife 10 2021 e60478 34633285 PMC8570691
  3. Arbab M. Srinivasan S. Hashimoto T. Geijsen N. Sherwood R.I. Cloning-free CRISPR Stem Cell Rep. 5 2015 908 917 PMC4649464 26527385
  4. Artegiani B. Hendriks D. Beumer J. Kok R. Zheng X. Joore I. Chuva de Sousa Lopes S. van Zon J. Tans S. Clevers H. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing Nat. Cell Biol. 22 2020 321 331 32123335
  5. Begue B. Verdier J. Rieux-Laucat F. Goulet O. Morali A. Canioni D. Hugot J.P. Daussy C. Verkarre V. Pigneur B. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease Am. J. Gastroenterol. 106 2011 1544 1555 21519361
  6. Beumer J. Puschhof J. Bauzá-Martinez J. Martínez-Silgado A. Elmentaite R. James K.R. Ross A. Hendriks D. Artegiani B. Busslinger G.A. High-resolution mRNA and secretome atlas of human enteroendocrine cells Cell 182 2020 1062 1064 32822568
  7. Bevins C.L. Salzman N.H. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis Nat. Rev. Microbiol. 9 2011 356 368 21423246
  8. Burclaff J. Bliton R.J. Breau K.A. Ok M.T. Gomez-Martinez I. Ranek J.S. Bhatt A.P. Purvis J.E. Woosley J.T. Magness S.T. A proximal-to-distal survey of healthy adult human small intestine and colon epithelium by single-cell transcriptomics Cell. Mol. Gastroenterol. Hepatol. 13 2022 1554 1589 35176508 PMC9043569
  9. Busslinger G.A. Weusten B.L.A. Bogte A. Begthel H. Brosens L.A.A. Clevers H. Human gastrointestinal epithelia of the esophagus, stomach, and duodenum resolved at single-cell resolution Cell Rep. 34 2021 108819 33691112
  10. Chiang H.Y. Lu H.H. Sudhakar J.N. Chen Y.W. Shih N.S. Weng Y.T. Shui J.W. IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence Nat. Commun. 13 2022 874 35169117 PMC8847568
  11. Clevers H.C. Bevins C.L. Paneth cells: maestros of the small intestinal crypts Annu. Rev. Physiol. 75 2013 289 311 23398152
  12. Cox J.H. Kljavin N.M. Ota N. Leonard J. Roose-Girma M. Diehl L. Ouyang W. Ghilardi N. Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice Mucosal Immunol. 5 2012 99 109 22089030
  13. Eken A. Singh A.K. Treuting P.M. Oukka M. IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism Mucosal Immunol. 7 2014 143 154 23715173 PMC3834084
  14. Forbester J.L. Lees E.A. Goulding D. Forrest S. Yeung A. Speak A. Clare S. Coomber E.L. Mukhopadhyay S. Kraiczy J. Interleukin-22 promotes phagolysosomal fusion to induce protection against Salmonella enterica Typhimurium in human epithelial cells Proc. Natl. Acad. Sci. USA. 115 2018 10118 10123 30217896 PMC6176607
  15. Fujii M. Matano M. Nanki K. Sato T. Efficient genetic engineering of human intestinal organoids using electroporation Nat. Protoc. 10 2015 1474 1485 26334867
  16. Gaudino S.J. Beaupre M. Lin X. Joshi P. Rathi S. McLaughlin P.A. Kempen C. Mehta N. Eskiocak O. Yueh B. IL-22 receptor signaling in Paneth cells is critical for their maturation, microbiota colonization, Th17-related immune responses, and anti-Salmonella immunity Mucosal Immunol. 14 2021 389 401 33060802 PMC7946635
  17. Glocker E.O. Kotlarz D. Boztug K. Gertz E.M. Schäffer A.A. Noyan F. Perro M. Diestelhorst J. Allroth A. Murugan D. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor N. Engl. J. Med. 361 2009 2033 2045 19890111 PMC2787406
  18. Hasegawa M. Yada S. Liu M.Z. Kamada N. Muñoz-Planillo R. Do N. Núñez G. Inohara N. Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage Immunity 41 2014 620 632 25367575 PMC4220303
  19. Jardé T. Chan W.H. Rossello F.J. Kaur Kahlon T. Theocharous M. Kurian Arackal T. Flores T. Giraud M. Richards E. Chan E. Mesenchymal Niche-Derived Neuregulin-1 Drives Intestinal Stem Cell Proliferation and Regeneration of Damaged Epithelium Cell Stem Cell 27 2020 646 662.e7 32693086
  20. Keir M. Yi T. Lu T. Ghilardi N. The role of IL-22 in intestinal health and disease J. Exp. Med. 217 2020 e20192195 32997932 PMC7062536
  21. Koblan L.W. Doman J.L. Wilson C. Levy J.M. Tay T. Newby G.A. Maianti J.P. Raguram A. Liu D.R. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction Nat. Biotechnol. 36 2018 843 846 29813047 PMC6126947
  22. Kok R.N.U. Hebert L. Huelsz-Prince G. Goos Y.J. Zheng X. Bozek K. Stephens G.J. Tans S.J. van Zon J.S. OrganoidTracker: Efficient cell tracking using machine learning and manual error correction PLoS One 15 2020 e0240802 33091031 PMC7580893
  23. Layunta E. Jäverfelt S. Dolan B. Arike L. Pelaseyed T. IL-22 promotes the formation of a MUC17 glycocalyx barrier in the postnatal small intestine during weaning Cell Rep. 34 2021 108757 33596425
  24. Lindemans C.A. Calafiore M. Mertelsmann A.M. O'Connor M.H. Dudakov J.A. Jenq R.R. Velardi E. Young L.F. Smith O.M. Lawrence G. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration Nature 528 2015 560 564 26649819 PMC4720437
  25. Mizoguchi A. Yano A. Himuro H. Ezaki Y. Sadanaga T. Mizoguchi E. Clinical importance of IL-22 cascade in IBD J. Gastroenterol. 53 2018 465 474 29075900 PMC5866830
  26. Pelczar P. Witkowski M. Perez L.G. Kempski J. Hammel A.G. Brockmann L. Kleinschmidt D. Wende S. Haueis C. Bedke T. A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease Science 354 2016 358 362 27846573
  27. Pleguezuelos-Manzano C. Puschhof J. van den Brink S. Geurts V. Beumer J. Clevers H. Establishment and culture of human intestinal organoids derived from adult stem cells Curr. Protoc. Immunol. 130 2020 e106 32940424 PMC9285512
  28. Reyes J.L. Fernando M.R. Lopes F. Leung G. Mancini N.L. Matisz C.E. Wang A. McKay D.M. IL-22 restrains tapeworm-mediated protection against experimental colitis via regulation of IL-25 expression PLoS Pathog. 12 2016 e1005481 27055194 PMC4824453
  29. Rothenberg M.E. Wang Y. Lekkerkerker A. Danilenko D.M. Maciuca R. Erickson R. Herman A. Stefanich E. Lu T.T. Randomized phase I healthy volunteer study of UTTR1147A (IL-22Fc): a potential therapy for epithelial injury Clin. Pharmacol. Ther. 105 2019 177 189 29952004
  30. Sabat R. Ouyang W. Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system Nat. Rev. Drug Discov. 13 2014 21 38 24378801
  31. Sanos S.L. Bui V.L. Mortha A. Oberle K. Heners C. Johner C. Diefenbach A. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells Nat. Immunol. 10 2009 83 91 19029903 PMC4217274
  32. Schmechel S. Konrad A. Diegelmann J. Glas J. Wetzke M. Paschos E. Lohse P. Göke B. Brand S. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status Inflamm. Bowel Dis. 14 2008 204 212 18022867
  33. Sonnenberg G.F. Fouser L.A. Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 Nat. Immunol. 12 2011 383 390 21502992
  34. Stefanich E.G. Rae J. Sukumaran S. Lutman J. Lekkerkerker A. Ouyang W. Wang X. Lee D. Danilenko D.M. Diehl L. Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases Biochem. Pharmacol. 152 2018 224 235 29608910
  35. Street K. Risso D. Fletcher R.B. Das D. Ngai J. Yosef N. Purdom E. Dudoit S. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics BMC Genom. 19 2018 477 PMC6007078 29914354
  36. Stuart T. Butler A. Hoffman P. Hafemeister C. Papalexi E. Mauck W.M. 3rd Hao Y. Stoeckius M. Smibert P. Satija R. Comprehensive Integration of Single-Cell Data Cell 177 2019 1888 1902.e21 31178118 PMC6687398
  37. Sugimoto K. Ogawa A. Mizoguchi E. Shimomura Y. Andoh A. Bhan A.K. Blumberg R.S. Xavier R.J. Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis J. Clin. Invest. 118 2008 534 544 18172556 PMC2157567
  38. Tirosh I. Izar B. Prakadan S.M. Wadsworth M.H. 2nd Treacy D. Trombetta J.J. Rotem A. Rodman C. Lian C. Murphy G. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq Science 352 2016 189 196 27124452 PMC4944528
  39. Turner J.E. Stockinger B. Helmby H. IL-22 mediates goblet cell hyperplasia and worm expulsion in intestinal helminth infection PLoS Pathog. 9 2013 e1003698 24130494 PMC3795034
  40. Uhlén M. Fagerberg L. Hallström B.M. Lindskog C. Oksvold P. Mardinoglu A. Sivertsson Å. Kampf C. Sjöstedt E. Asplund A. Proteomics. tissue-based map of the human proteome Science 347 2015 1260419 25613900
  41. Yang Q. Bermingham N.A. Finegold M.J. Zoghbi H.Y. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine Science 294 2001 2155 2158 11739954
  42. Zenewicz L.A. Yancopoulos G.D. Valenzuela D.M. Murphy A.J. Stevens S. Flavell R.A. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease Immunity 29 2008 947 957 19100701 PMC3269819
  43. Zha J.M. Li H.S. Lin Q. Kuo W.T. Jiang Z.H. Tsai P.Y. Ding N. Wu J. Xu S.F. Wang Y.T. Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5(+) Stem cells via inhibition of Wnt and notch signaling Cell. Mol. Gastroenterol. Hepatol. 7 2019 255 274 30686779 PMC6352747
  44. Zhang Z. Zou J. Shi Z. Zhang B. Etienne-Mesmin L. Wang Y. Shi X. Shao F. Chassaing B. Gewirtz A.T. IL-22-induced cell extrusion and IL-18-induced cell death prevent and cure rotavirus infection Sci. Immunol. 5 2020 eabd2876 33008915 PMC7709835
  45. Zhou Y. Rychahou P. Wang Q. Weiss H.L. Evers B.M. TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium Cell Death Dis. 6 2015 e1631 25654764 PMC4669793
  46. Zwarycz B. Gracz A.D. Rivera K.R. Williamson I.A. Samsa L.A. Starmer J. Daniele M.A. Salter-Cid L. Zhao Q. Magness S.T. IL22 inhibits epithelial stem cell expansion in an Ileal organoid model Cell. Mol. Gastroenterol. Hepatol. 7 2019 1 17 30364840 PMC6199238

Cited by

Sorted by citations

Authors
He, G.-W., Lin, L., DeMartino, J., Zheng, X., Staliarova, N., Dayton, T., Begthel, H., van de Wetering, W. J., Bodewes, E., van Zon, J., Tans, S., Lopez-Iglesias, C., Peters, P. J., Wu, W., Kotlarz, D., Klein, C., Margaritis, T., Holstege, F., & Clevers, H.
Affiliations
  • Royal Netherlands Academy of Arts and Sciences (NL)
  • Princess Máxima Center (NL)
  • Institute for Atomic and Molecular Physics (NL)
  • Utrecht University (NL)
  • Maastricht University (NL)
  • Agency for Science, Technology and Research (SG)
  • Ludwig-Maximilians-Universität München (DE)
Corresponding author
Clevers, Hans
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2022-09
Volume
29
Issue
9
Pages
1333-1345.e6
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W4292756165
Cited by
178
References
7
Citations by year
2026: 45 · 2025: 55 · 2024: 50 · 2023: 23 · 2022: 5
FWCI
12.70
Type
journal article
Language
en
Update notices
erratum (2022-12-01)
Open access
Locations
  • Cell stem cell (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc-nd)
  • AMOLF Institutional Repository (AMOLF) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • NWO (2019.085, 737.016.009, 024.003.001)
  • Ministerie van Onderwijs, Cultuur en Wetenschap
  • Horizon 2020 (668294)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Digestive system and related health
Keywords
IL-22, Paneth cells, intestinal stem cells, IL10RB, inflammatory bowel disease, host defense genes, REG1A, REG1B, DMBT1, tuft cells, goblet cells, enterocytes
MeSH terms
Interleukin-22, Calcium-Binding Proteins, DNA-Binding Proteins, Humans, Interleukins, Intestinal Mucosa, Intestine, Small, Organoids, Paneth Cells, Tumor Suppressor Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review